Assembly Biosciences, Inc. Deferred Income Tax Liabilities, Net
Assembly Biosciences, Inc. (ASMB) had Deferred Income Tax Liabilities, Net of $2.53 million as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2022-03-11
- 2021-09-30: Deferred Income Tax Liabilities, Net $2.53M.
- 2021-06-30: Deferred Income Tax Liabilities, Net $2.53M.
- 2021-03-31: Deferred Income Tax Liabilities, Net $2.53M.
- 2020-12-31: Deferred Income Tax Liabilities, Net $2.53M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2021-09-30 | $2.53M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.53M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.53M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.53M 10-K · filed 2022-03-11 |
| 2020-09-30 | $2.53M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.53M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.53M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.53M 10-K · filed 2021-02-25 |
| 2019-09-30 | $3.25M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $3.25M 10-Q · filed 2019-08-05 |
| 2018-12-31 | $3.25M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |